Insulet Corp. logo
PODDInsulet Corp.

Is the current ratio high or low?

The current ratio of 2.49 is 38% below its 5-year average of 4.02, near the low end of its 5-year range (2.23–6.36).

As of Thursday, June 25, 2026. 16.01% below its 12-month average of 2.96.

Quick Ratio|Debt to Equity|P/B Ratio|All Metrics
Current Ratio

PODD Current Ratio

2.49

Reported quarterly current ratio; no daily interpolation.

-57.25% 5Y
PODD Current Ratio

PODD Average Current Ratio Chart

PODD Current Ratio

PODD Current vs Average Current Ratio Chart

PODD Current Ratio Metrics

CURRENT RATIO

2.49

CURRENT RATIO AVG TTM

2.96

CURRENT RATIO AVG 3Y

3.28

CURRENT RATIO AVG 5Y

4.02

CURRENT RATIO AVG 10Y

4.74

CURRENT RATIO AVG 15Y

4.59

CURRENT RATIO AVG 20Y

4.67

CURRENT VS TTM AVG

-16.01%

CURRENT VS 3Y AVG

-24.25%

CURRENT VS 5Y AVG

-38.07%

CURRENT VS 10Y AVG

-47.60%

CURRENT VS 15Y AVG

-45.82%

CURRENT VS 20Y AVG

-46.72%

PODD Competitors' Current Ratio

NAMEMARKET CAPCURRENT RATIOTTM3Y5Y
Insulet Corp. (PODD)$10.31B2.492.963.284.02
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B0.680.660.700.70
Baxter International Inc. (BAX)vs ›$10.87B2.311.831.711.91
Charles River Laboratories International, Inc. (CRL)vs ›$9.73B1.291.351.391.37
Henry Schein, Inc. (HSIC)vs ›$9.38B1.381.401.561.60
Revvity, Inc. (RVTY)vs ›$11.78B1.682.642.372.14
Align Technology, Inc. (ALGN)vs ›$12.24B1.361.291.261.29
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.57B5.626.055.874.96
Oscar Health, Inc. (OSCR)vs ›$7.56B0.950.931.041.20
Solventum Corporation (SOLV)vs ›$13.09B1.231.211.401.43

Liquidity Analysis

Current Ratio

2.49

Quick Ratio

2.11

Current Ratio Formula & Definition

Current Ratio = Current Assets / Current Liabilities

The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Current Ratio FAQ

What is the current ratio for Insulet Corp. (PODD)?
The current ratio for PODD stock is 2.49.
Is Insulet Corp.'s current ratio high or low?
The current ratio of 2.49 is 38% below its 5-year average of 4.02, near the low end of its 5-year range (2.23–6.36).
What is the TTM average current ratio for Insulet Corp. (PODD)?
The TTM average current ratio for PODD stock is 2.96.
What is the 3Y average current ratio for Insulet Corp. (PODD)?
The 3Y average current ratio for PODD stock is 3.28.
What is the 5Y average current ratio for Insulet Corp. (PODD)?
The 5Y average current ratio for PODD stock is 4.02.
What is the 10Y average current ratio for Insulet Corp. (PODD)?
The 10Y average current ratio for PODD stock is 4.74.
What is the 15Y average current ratio for Insulet Corp. (PODD)?
The 15Y average current ratio for PODD stock is 4.59.
What is the 20Y average current ratio for Insulet Corp. (PODD)?
The 20Y average current ratio for PODD stock is 4.67.

PODD Current Ratio History

DATECURRENT RATIO
2026-03-312.49
2025-12-312.78
2025-09-302.87
2025-06-302.23
2025-03-314.43
2024-12-313.54
2024-09-303.64
2024-06-303.56
2024-03-313.70
2023-12-313.47
2023-09-303.22
2023-06-303.31
2023-03-313.43
2022-12-313.56
2022-09-303.93
2022-06-304.64
2022-03-315.92
2021-12-315.75
2021-09-305.66
2021-06-305.82
2021-03-316.36
2020-12-315.96
2020-09-306.56
2020-06-308.00
2020-03-314.08
2019-12-313.69
2019-09-306.93
2019-06-304.64
2019-03-314.29
2018-12-313.93
2018-09-304.51
2018-06-305.46
2018-03-315.40
2017-12-316.24
2017-09-304.88
2017-06-307.05
2017-03-318.56
2016-12-316.64
2016-09-306.67
2016-06-303.29
2016-03-313.45
2015-12-312.93
2015-09-303.27
2015-06-303.87
2015-03-314.34
2014-12-314.70
2014-09-304.33
2014-06-303.26
2014-03-314.64
2013-12-314.68
2013-09-304.13
2013-06-305.82
2013-03-314.53
2012-12-312.28
2012-09-302.30
2012-06-302.68
2012-03-313.91
2011-12-314.71
2011-09-305.57
2011-06-305.56
2011-03-317.95
2010-12-317.52
2010-09-306.52
2010-06-306.13
2010-03-317.93
2009-12-317.79
2009-09-305.48
2009-06-304.79
2009-03-315.05
2008-12-315.22
2008-09-306.70
2008-06-308.04
2008-03-313.49
2007-12-315.17
2007-09-305.90
2007-06-307.50
2007-03-310.67
2006-12-311.02
2006-09-303.16
2006-06-300.00
2006-03-310.00
2005-12-312.14
2005-09-300.00
2005-06-300.00
2005-03-310.00

Related Metrics

Quick RatioDebt to EquityP/B RatioAll Metrics

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
www.insulet.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy
View full financials